Excipient

Lipid-Based Drug Delivery in Modern Pharmaceutical Development to be Presented by Catalent and BASF at Forthcoming Workshop

Retrieved on: 
torsdag, september 20, 2018
Dosage forms, Pharmacology, Health, Pharmacy, Catalent, Softgel, Drug delivery, Excipient, Formulation

Attendees will develop a better understanding of excipients, lipid-based drug delivery system (LBDDS) formulation development, and softgel technology, to help them overcome development challenges and advance their drug molecules into a drug product.

Key Points: 
  • Attendees will develop a better understanding of excipients, lipid-based drug delivery system (LBDDS) formulation development, and softgel technology, to help them overcome development challenges and advance their drug molecules into a drug product.
  • "Early Phase Screening Approach for Lipid Formulations" by Giang (Ellie) Au, Ph.D., Scientist, Product Development, Catalent Pharma Solutions.
  • "Bioavailability and Beyond: Innovations in Softgel Formulation and Manufacturing to Advance More Molecules" by Mr. Stephen Tindal, Catalent Pharma Solutions.
  • Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.

Excipients in Pharmaceuticals: Global Markets to 2022

Retrieved on: 
tisdag, juli 24, 2018
Pharmacology, Health, Pharmacy, Pharmaceutical industry, Excipient, Dosage form, Pharmaceutics

Emerging pharmaceutical excipients such as co-processed and multifunctional excipients and their impact on the future of pharmaceutical excipients market is also analyzed.

Key Points: 
  • Emerging pharmaceutical excipients such as co-processed and multifunctional excipients and their impact on the future of pharmaceutical excipients market is also analyzed.
  • Based on the type of material, the pharmaceutical excipient market is segmented into organic excipients, inorganic excipients and USP Water.Based on route of administration, the pharmaceutical excipient market is segmented by-oral, injectable/parenteral, topical and advanced delivery systems.
  • By dosage forms, the pharmaceutical excipients market is segmented as solid dosage forms, liquid dosage forms, semi-solid dosage forms, and others (e.g., aerosol and powder).
  • Emerging pharmaceutical excipients such as co-processed and multifunctional excipients and their impact on the future of pharmaceutical excipients market is also analyzed.

Global Excipients in Pharmaceuticals Markets 2018-2022: Major Players are Ashland Global, Cargill, Meggle Pharma, The Lubrizol Corporation and Omya

Retrieved on: 
måndag, juli 23, 2018
Pharmacology, Pharmaceutical industry, Health, Excipient, Pharmacy, Dosage forms, Chemical engineering

This report on the pharmaceutical excipient market covers an overview of excipients, classification of excipients, and their significance in the pharmaceutical industry.

Key Points: 
  • This report on the pharmaceutical excipient market covers an overview of excipients, classification of excipients, and their significance in the pharmaceutical industry.
  • Emerging pharmaceutical excipients such as co-processed and multifunctional excipients and their impact on the future of pharmaceutical excipients market are also analyzed.
  • Company profiles of major players in the market, including Ashland Global Holdings, Inc., Cargill, Inc, Meggle Pharma Gmbh, The Lubrizol Corporation and Omya AG
    Based on the type of material, the pharmaceutical excipient market is segmented into organic excipients, inorganic excipients, and USP Water.
  • By dosage forms, the pharmaceutical excipients market is segmented as solid dosage forms, liquid dosage forms, semi-solid dosage forms, and others (e.g., aerosol and powder).

Biologic Excipients Market Poised to Register 3.6% CAGR Through 2028

Retrieved on: 
torsdag, juli 5, 2018
Pharmaceutical industry, Excipient, Pharmacy

Future Market Insights (FMI) delivers key insights on the global biologic excipients market in its upcoming report titled " Biologic Excipients Market : Global Industry Analysis 2013-2017 and Opportunity Assessment 2018 - 2028".

Key Points: 
  • Future Market Insights (FMI) delivers key insights on the global biologic excipients market in its upcoming report titled " Biologic Excipients Market : Global Industry Analysis 2013-2017 and Opportunity Assessment 2018 - 2028".
  • Polymers biologic excipients are anticipated to lead the biologic excipients market over the forecast period.
  • A key trend witnessed in the biologic excipients market is increasing adoption of continuous processing of biologic excipients, dependence of large drug manufacturers on in-house biologic excipients production, vast proportion of imported excipients leading to production delays, and regulatory harmonisation with respect to gradation of excipients.
  • The North America regional market is projected to dominate the global biologic excipients market, accounting for a maximum revenue share of the global market by 2017 end.

Ideal Cures Launches Two New Film Coating Products INSTACOAT QD and INSTACOAT T2F at the 2nd FDD Conclave

Retrieved on: 
onsdag, juli 4, 2018
Pharmacy, Chemistry, Coatings, Pharmaceutical industry, Polymers, Pharmacokinetics, Film coating, Excipient, Dosage form, Pharma

Ideal Cures, an Indian company headquartered in Mumbai, India, launched two new ready-to-use film coating products INSTACOAT QD and INSTACOAT T2F, at the 2nd Formulation and Drug Delivery Conclave (FDD), held on 15th-16th June 2018, at Hyderabad, India where more than 110 formulators of top India based pharma companies were present.

Key Points: 
  • Ideal Cures, an Indian company headquartered in Mumbai, India, launched two new ready-to-use film coating products INSTACOAT QD and INSTACOAT T2F, at the 2nd Formulation and Drug Delivery Conclave (FDD), held on 15th-16th June 2018, at Hyderabad, India where more than 110 formulators of top India based pharma companies were present.
  • INSTACOAT QD, quick disintegrating film coating product is revolutionary for pharmaceutical applications which provides fast disintegration of film within 3-30 seconds.
  • INSTACOAT T2F is a brilliant ready-to-use coating product by Ideal Cures that is completely free from Talc and TiO2.
  • Ideal Cures (IC) is amongst India's leading manufacturer and exporter of pharmaceutical excipients and ready-to-use coating systems for solid oral dosage forms.

Global Pharmaceutical Excipients Market 2018-2026 - Market is Expected to Reach US$ 11,938.1 Million

Retrieved on: 
fredag, juni 15, 2018
Pharmaceutical industry, Pharmacology, Health, Excipient, Pharmacy, Chemistry, Diluent, BASF

The global pharmaceutical excipients market was valued at US$ 6,615.7 Mn in 2017 and expected to reach US$ 11,938.1 Mn by 2026 expanding at a CAGR of 6.87 % from 2018 to 2026.

Key Points: 
  • The global pharmaceutical excipients market was valued at US$ 6,615.7 Mn in 2017 and expected to reach US$ 11,938.1 Mn by 2026 expanding at a CAGR of 6.87 % from 2018 to 2026.
  • Polymers segment currently dominates the pharmaceutical excipients market due to its vast application in drug formulation from conventional to novel drug delivery systems.
  • Fillers and diluents comprises nearly 42% of the pharmaceutical excipients market and is the leading segment by function.
  • Domicile of key players such as BASF SE and Roquette Group in the Western European region mainly define the pharmaceutical excipients market in Europe.

Global Pharmaceutical Excipients Market 2018-2023: Multifunctionality Excipients are Proving to Be Emerging Areas of New Product Development

Retrieved on: 
torsdag, april 19, 2018
Health, Pharmaceutical industry, Pharmacology, Pharmacy, Excipient, Dosage forms, Tablet, Organic food

The global pharmaceutical excipients market is projected to reach USD 8.53 Billion by 2023 from USD 6.40 Billion in 2018, growing at a CAGR of 5.9%.

Key Points: 
  • The global pharmaceutical excipients market is projected to reach USD 8.53 Billion by 2023 from USD 6.40 Billion in 2018, growing at a CAGR of 5.9%.
  • The report analyzes the market by product, functionality, type of formulation, and region.
  • Based on product, the organic chemical excipients segment accounted for the largest share of the market in 2017.
  • With the development of excipients to improve the functionality of active pharmaceutical ingredients (APIs) in tablets and capsules, the demand for these formulations is high.